Vara Raises €4.5M in Extension Funding
Summary
Vara, a Berlin, Germany-based provider of an AI breast cancer screening platform, raised €4.5m in extension funding. The round, which takes the total Series A funding raised to €11m, was led by VI Partners with participation from EQT Foundation, Med 360, AI Venture Studio, Merantix, as well as Think Health. The company intends to use the funds to complete its wide-scale clinical study* of AI and workflow software in breast cancer screening, with an expected recruitment of 400,000 screening-age women. * Vara’s PRAIM (PRospective multicenter observational study of an integrated artificial intelligence (AI) system with live Monitoring) study, which is due to run until mid-2023, is led by Prof. Dr. Alexander Katalinic, Director of Social Medicine and Epidemiology at the University of Lübeck and scientific advisor to the German Mammography Screening Program. When completed, the results of this study will be a part of Vara’s growing clinical evidence base, published in the likes of the Lancet Digital Health and the European Journal of Radiology.